Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Highlights • COMBI-APlus met its primary endpoint of reduction in the composite rate of pyrexia. • Pyrexia composite rate = grade 3/4 incidence, hospitalisation, and discontinuation. • The adapted pyrexia management algorithm interrupted both drugs for pyrexia. • Overall safety and early efficacy in COMBI-APlus were consistent with COMBI-AD.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
